Skip to main content
. 2023 Apr 13;14:1120827. doi: 10.3389/fgene.2023.1120827

FIGURE 8.

FIGURE 8

Immune-related function analysis and drug sensitivity. (A) Immune-related function analysis of CRLs. (B) Tumor immune dysfunction and exclusion (TIDE) algorithm analysis for high-risk and low-risk groups. Drug sensitivity of CP-466722, crizotinib, MS-275, KIN001-135, CP-466722 (C–G).